Search results for "TC"

showing 10 items of 9993 documents

Effectiveness of the Cognitive Differentiation Program of the Integrated Psychological Therapy

2011

The aim of the current pilot study was to compare two strategies in the application of the cognitive differentiation program of Integrated Psychological Therapy for people with schizophrenia. Twenty-six outpatients were randomly assigned to the application of the program in group sessions (CDg), or to its application in individualized sessions (CDi). The program provides cognitive exercises to promote better performance in cognition, and both groups of participants completed the same number of exercises following the same number of sessions per week. Outcomes were assessed on neuropsychological measures of attention, executive functioning and everyday memory, and everyday functioning. Effec…

AdultMalePsychological therapyPilot ProjectsNeuropsychological Testslaw.inventionRandomized controlled triallawmedicineHumansSingle-Blind MethodSocial functioningCognitive Behavioral TherapyNeuropsychologyCognitionMiddle Agedmedicine.diseasePsychiatry and Mental healthTreatment OutcomeCognitive remediation therapySchizophreniaPsychotherapy GroupFemaleCognition DisordersPsychologyEveryday memoryClinical psychologyJournal of Nervous & Mental Disease
researchProduct

Liebowitz Social Anxiety Scale (LSAS): Optimal cut points for remission and response in a German sample

2017

The Liebowitz Social Anxiety Scale (LSAS) is the most frequently used instrument to assess social anxiety disorder (SAD) in clinical research and practice. Both a self-reported (LSAS-SR) and a clinician-administered (LSAS-CA) version are available. The aim of the present study was to define optimal cut-off (OC) scores for remission and response to treatment for the LSAS in a German sample. Data of N = 311 patients with SAD were used who had completed psychotherapeutic treatment within a multicentre randomized controlled trial. Diagnosis of SAD and reduction in symptom severity according to the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, 4th editi…

AdultMalePsychometricsLiebowitz social anxiety scaleSensitivity and Specificitylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawGermanyHumansPsychiatric Status Rating ScalesReceiver operating characteristicRemission InductionSocial anxietyNonparametric statisticsReproducibility of ResultsPhobia SocialGold standard (test)030227 psychiatryPsychotherapyClinical PsychologyTreatment OutcomeClinical researchFemalePsychology030217 neurology & neurosurgeryCut-pointClinical psychologyClinical Psychology & Psychotherapy
researchProduct

The factor structure of the Medical Outcomes Study-Social Support Survey: A comparison of different models in a sample of recently diagnosed cancer p…

2018

[EN] Objective: To analyse the factor structure and psychometric properties of the original and abbreviated versions of the Medical Outcomes Study-Social Support Survey (MOS-SSS) in recently-diagnosed cancer patients. Method: A sample of 128 newly-diagnosed cancer patients were assessed with the Spanish versions of the MOS-SSS and the Hospital Anxiety and Depression Scale (HADS). Confirmatory factor analyses were conducted to analyse six different factor structures. Internal consistency and convergent validity indexes were calculated. The models tested included all of the following: 1) the original five-factor model (comprised of the following dimensions: emotional, informational, and tangi…

AdultMalePsychometricsPsychometricsESTADISTICA E INVESTIGACION OPERATIVAPsychological distressHospital Anxiety and Depression ScaleConfirmatory factor analysisSocial supportYoung Adult03 medical and health sciencesSocial support0302 clinical medicineNeoplasmsSurveys and QuestionnairesOutcome Assessment Health CareHumansLongitudinal Studies030212 general & internal medicineSurveyMedical Outcomes Study - Social SupportAgedFactor analysisCancerReproducibility of ResultsMiddle AgedSocial relationConfirmatory factor analysisPsychiatry and Mental healthClinical PsychologyConvergent validity030220 oncology & carcinogenesisScale (social sciences)FemalePsychologyClinical psychology
researchProduct

Two-year outcome in first-episode psychosis treated according to an integrated model. Is immediate neuroleptisation always needed?

2000

SummaryIn this multicentre study the two-year outcome of two groups of consecutive patients (total N = 106) with first-episode functional non-affective psychosis, both treated according to the ‘need-specific Finnish model’, which stresses teamwork, patient and family participation and basic psychotherapeutic attitudes, was compared. No alternative treatment facilities were available in the study sites. The two study groups differed in the use of neuroleptics: three of the sites (the experimental group) used a minimal neuroleptic regime whilst the other three (the control group) used neuroleptics according to the usual practice. Total time spent in hospital, occurrence of psychotic symptoms …

AdultMalePsychosismedicine.medical_specialtyAdolescentChlorpromazine050109 social psychologyOutcome (game theory)Catchment Area HealthmedicineHumansPsychiatric hospital0501 psychology and cognitive sciencesPsychiatryFinlandPatient Care Teambusiness.industryPublic health05 social sciences050301 educationSocial environmentMiddle Agedmedicine.diseaseMental healthClinical trialPsychiatry and Mental healthTreatment OutcomePsychotic DisordersPhysical therapyFemalebusinessAttitude to Health0503 educationPsychosocialAntipsychotic AgentsEuropean Psychiatry
researchProduct

Prediction of acute clinical response following a first episode of non affective psychosis: results of a cohort of 375 patients from the Spanish PAFI…

2013

Abstract Objective Predicting response to antipsychotic treatment might optimize treatment strategies in early phases of schizophrenia. We aimed to investigate sociodemographic, premorbid and clinical predictors of response to antipsychotic treatment after a first episode of non-affective psychosis. Method 375 (216 males) patients with a diagnosis of non affective psychosis entered the study. The main outcome measure was clinical response at 6 weeks and variables at baseline were evaluated as predictors of response. ANOVA for continuous and chi-square for categorical data were used to compare responders and non-responders. Multivariate logistic regression was used to establish a prediction …

AdultMalePsychosismedicine.medical_specialtyAdolescentLogistic regressionCohort StudiesYoung AdultPredictive Value of TestsOutcome Assessment Health CaremedicineHumansFamily historyPsychiatryBiological PsychiatryRetrospective StudiesPharmacologyFirst episodePsychiatric Status Rating ScalesAnalysis of VarianceChi-Square DistributionMiddle Agedmedicine.diseaseLogistic ModelsPsychotic DisordersSchizophreniaSpainCohortdupFemalePsychologyDiagnosis of schizophreniaAntipsychotic AgentsProgress in neuro-psychopharmacologybiological psychiatry
researchProduct

Seroquel (ICI 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and cha…

1995

Preclinical data indicated that seroquel (ICI 204 636), a dibenzothiazepine with 5-HT2 and D2-like receptor antagonistic properties, might be an effective antipsychotic agent, causing fewer extrapyramidal side effects than typical neuroleptics. In the present study, 12 patients suffering from schizophrenia or schizophreniform disorder with predominantly positive symptomatology were treated in an open clinical trial for 4 weeks with seroquel at a maximum dosage of 750 mg/day. The drug was generally well tolerated, and virtually no adverse extrapyramidal side effects such as acute dystonia, parkinsonism or akathisia were observed. Total scores for BPRS (item score 0–6; baseline: 42.0±2.3; mea…

AdultMalePsychosismedicine.medical_specialtyDibenzothiazepinesTime Factorsmedicine.drug_classmedicine.medical_treatmentAtypical antipsychoticThyrotropinAkathisiaGastroenterologyQuetiapine FumarateAntipsychotic AgentInternal medicinemedicineHumansSchizophreniform disorderAntipsychoticAgedPharmacologyPsychiatric Status Rating ScalesParkinsonismElectroencephalographyMiddle Agedmedicine.diseaseProlactinTreatment OutcomeSchizophreniaAnesthesiaSchizophreniaFemaleSchizophrenic Psychologymedicine.symptomPsychologyAntipsychotic AgentsPsychopharmacology
researchProduct

The relevance of cognitive, clinical and premorbid variables in predicting functional outcome for individuals with first-episode psychosis: A 3 year …

2013

Real-world functional deficits are common and persistent in individuals with psychosis. Cognitive deficits have been shown to compromise functioning. We aimed to study the predictive values of premorbid, sociodemographic, and baseline clinical and neurocognitive factors on long-term functional outcome for individuals with first episode non-affective psychosis. We failed to demonstrate a significant relationship between cognitive deficits at baseline and functional disability at 3 year follow-up. Diagnosis of schizophrenia (OR=2.457, p=0.011), shorter education (OR=1.177, p=0.005) and poor premorbid social adjustment (OR=1.628, p=0.013) emerged as the strongest predictors for the 114 subject…

AdultMalePsychosismedicine.medical_specialtyLongitudinal studyAdolescentNeuropsychological TestsOutcome (game theory)Disability EvaluationYoung AdultPredictive Value of TestsmedicineHumansLongitudinal StudiesPsychiatryBiological PsychiatryRetrospective StudiesFirst episodeCognitionMiddle AgedPrognosismedicine.diseasePsychiatry and Mental healthLogistic ModelsPsychotic DisordersSocioeconomic FactorsSchizophreniaFemaleCognition DisordersPsychologyNeurocognitiveAntipsychotic AgentsDiagnosis of schizophreniaPsychiatry Research
researchProduct

Familial liability to schizophrenia and mood disorders and cognitive impairment in psychosis.

2015

Schizophrenia and other psychoses are complex disorders with high rates of cognitive impairment and a considerable degree of genetic and environmental influence on its etiology. Whether cognitive impairment is related to dimensional scores of familial liability is still matter of debate. We conducted a cross-sectional study including 169 patients with psychotic disorders and 26 healthy controls. Attention, memory and executive functions were assessed, and familial loading scores for schizophrenia and mood disorders were calculated. The relationships between familial liability and neuropsychological performance were examined with Spearman׳s correlation coefficients. In addition, patients wer…

AdultMalePsychosismedicine.medical_specialtyMatched-Pair Analysisbehavioral disciplines and activitiesSeverity of Illness IndexExecutive FunctionVisual memoryMemorymental disordersSeverity of illnessmedicineHumansAttentionBipolar disorderPsychiatryBiological PsychiatryMood DisordersNeuropsychologymedicine.diseaseExecutive functionsPsychiatry and Mental healthCross-Sectional StudiesMood disordersPsychotic DisordersSchizophreniaSchizophreniaFemalePsychologyCognition DisordersClinical psychologyPsychiatry research
researchProduct

Duration of active psychosis and functional outcomes in first-episode non-affective psychosis.

2018

AbstractBackground:The duration of untreated psychosis (DUP) has been associated with negative outcomes in psychosis; however, few studies have focused on the duration of active psychotic symptoms after commencing treatment (DAT). In this study, we aimed to evaluate the effect of DUP and DAT on functional long-term outcomes (3 years) in patients with early psychosis.Methods:We evaluated the Scale for the Assessment of Positive Symptoms (SAPS) at frequent intervals for 3 years after presentation to determine the DAT for 307 individuals with first-episode psychosis together with DUP and clinical variables. The functional outcomes were assessed using the Disability Assessment Scale (DAS) at th…

AdultMalePsychosismedicine.medical_specialtyTime FactorsLogistic regressionCohort Studies03 medical and health sciencesDisability Evaluation0302 clinical medicineActivities of Daily LivingmedicineHumansProspective StudiesPsychiatryProspective cohort studyFirst episodePsychiatric Status Rating ScalesReceiver operating characteristicbusiness.industrymedicine.disease030227 psychiatryPsychiatry and Mental healthTreatment OutcomePsychotic DisordersSchizophreniaNon affective psychosisdupSchizophreniaFemaleSchizophrenic PsychologybusinessSocial Adjustment030217 neurology & neurosurgeryAntipsychotic AgentsEuropean psychiatry : the journal of the Association of European Psychiatrists
researchProduct

Therapist competence and therapeutic alliance are important in the treatment of health anxiety (hypochondriasis)

2015

The role of treatment delivery factors (i.e., therapist adherence, therapist competence, and therapeutic alliance) is rarely investigated in psychotherapeutic treatment for health anxiety. This study aimed to investigate the role of the assessment perspective for the evaluation of treatment delivery factors and their relevance for treatment outcome. Therapist adherence, therapist competence, and therapeutic alliance were evaluated by independent raters, therapists, patients, and supervisors in 68 treatments. Patients with severe health anxiety (hypochondriasis) were treated with cognitive therapy or exposure therapy. Treatment outcome was assessed with a standardized interview by independen…

AdultMalePsychotherapistmedicine.medical_treatmentExposure therapyTreatment outcomeImplosive Therapybehavioral disciplines and activitiesProfessional CompetencemedicineHumansCompetence (human resources)Biological PsychiatryCognitive Behavioral TherapyProfessional-Patient RelationsMiddle AgedHypochondriasisPsychiatry and Mental healthTreatment OutcomeAllianceStructured interviewCognitive therapyPatient ComplianceAnxietyFemaleImplosive Therapymedicine.symptomPsychologyhuman activitiesClinical psychologyPsychiatry Research
researchProduct